Suchergebnisse - "Stanic, Mijo"

PubPharm (9)

1

ICH Q14-inspired novel approach to establish an SFC-based purity method for carbamazepine

enthalten in: Drug testing and analysis | 2024

von Schmidt, A. | Stanic, M. | Parr, M.

2

Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial - the potential of enantiomeric separation for doping control analysis

enthalten in: Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment | 2017

von Parr, M. | Blokland, M. | Liebetrau, F. | +6

3

SFC-MS/MS as an orthogonal technique for improved screening of polar analytes in anti-doping control

enthalten in: Analytical and bioanalytical chemistry | 2016

von Parr, M. | Wuest, B. | Naegele, E. | +6

4

SFC-MS/MS as an orthogonal technique for improved screening of polar analytes in anti-doping control

enthalten in: Analytical and bioanalytical chemistry | 2016

von Parr, M. | Wuest, B. | Naegele, E. | +6

5

SFC-MS/MS as an orthogonal technique for improved screening of polar analytes in anti-doping control

enthalten in: Analytical & bioanalytical chemistry | 2016

von Parr, M. | Wuest, B. | Naegele, E. | +6

6

SFC-MS/MS as an orthogonal technique for improved screening of polar analytes in anti-doping control

enthalten in: Analytical and bioanalytical chemistry | 2016

von Parr, M. | Wuest, B. | Naegele, E. | +6

7

In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling—Case study pramipexole

enthalten in: Journal of pharmaceutical and biomedical analysis | 2014

von Schmidt, A. | Stanic, M. | Molnár, I.

8

In silico robustness testing of a compendial HPLC purity method by using of a multidimensional design space build by chromatography modeling-Case study pramipexole

enthalten in: Journal of pharmaceutical and biomedical analysis | 2014

von Schmidt, A. | Stanic, M. | Molnár, I.

9

Rapid UHPLC Method Development for Omeprazole Analysis in a Quality-by-Design Framework and Transfer to HPLC Using Chromatographic Modeling - Quality-by-design principles are applied to build in a more scientific and risk-based multifactorial strategy in the development of a UHPLC method for analyzing a drug and its related impurities.

enthalten in: LC, GC North America | 2014

von Schmidt, A. | Stanic, M.

1
[1]